Federal data shows opioid shipments ballooned by over 50pc as crisis grew Medical Dialogues Bureau18 July 2019 9:00 AM ISTWhile OxyContin is the best-known prescription opioid, the Post analysis shows that Purdue accounted for just 3% of pills sold during that time. Three...
Methodology to Fix Prices of Essential Medicines- Minister informs Parliament Farhat Nasim17 July 2019 4:07 PM ISTNew Delhi: Through a recent reply, the Minister in the Ministry of Chemical and Fertilizers informed the Parliament about the details of the...
USFDA finds adulteration, violations of CGMP regulations at Strides Pharma Puducherry plant Farhat Nasim17 July 2019 1:59 PM ISTThe FDA's warning letter dated July 1, comes months after several Indian drugmakers including Sun Pharmaceutical Ltd and Dr Reddy's Laboratories Ltd...
Despite legal hassles, JnJ beats profit estimates on pharma strength Medical Dialogues Bureau17 July 2019 12:10 PM ISTJohnson and Johnson's (JnJ) pharmaceuticals unit has cushioned the impact of slow growth in its medical device and consumer health units, largely due...
Abbott to increase production of lower-cost glucose monitors as diabetes soars Medical Dialogues Bureau17 July 2019 9:30 AM ISTCHICAGO: Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to...
Novartis sickle cell drug crizanlizumab secures speedy USFDA review Medical Dialogues Bureau17 July 2019 9:26 AM ISTNovartis submitted the application for crizanlizumab for the prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and...
Takeda Pharma launches Rare Disease Therapies in India Medical Dialogues Bureau17 July 2019 9:25 AM ISTUnder lysosomal storage disorders, India has been recording the prevalence of Hunter syndrome, Gaucher disease and Fabry disease, Takeda said in a...
Cipla, Jiangsu Acebright join hands to invest USD 30 million for respiratory products in China Farhat Nasim16 July 2019 1:53 PM ISTWhile Cipla EU will hold 80 per cent stake in the joint venture, the rest 20 per cent will be with Acebright, the statement by Cipla said. Mumbai:...
USFDA issues warning letter to Indoco Remedies for Goa plant Medical Dialogues Bureau16 July 2019 11:39 AM ISTThe facility had received six observations in Form 483s and was classified as Official Action Indicated in March. Indoco Remedies responded to these...
Natco Pharma gets zero USFDA observations for Chennai facility Medical Dialogues Bureau16 July 2019 9:30 AM ISTNatco Pharma announced "successful completion of regulatory inspection from the US Food and Drug Administration (USFDA) for its active pharmaceutical...
GSK drug Zejula helps ovarian cancer patients live longer in late-stage study Medical Dialogues Bureau16 July 2019 9:26 AM ISTGSK bought the drug when it acquired U.S. cancer specialist Tesaro for $5.1 billion in December and Zejula is already approved for certain ovarian...
AstraZeneca Farxiga fails to win USFDA approval for Type-1 diabetes Medical Dialogues Bureau16 July 2019 9:25 AM ISTAstraZeneca said USFDA issued a complete response letter, declining its application for using the drug in patients with Type-1 diabetes where insulin...
